586 Appendices 584. Mirallie E, Borel F, Tresallet C, Hamy A, Mathonnet M, Lifante JC, et al. Impact of total thyroidectomy on quality of life at 6 months: the prospective ThyrQoL multicentre trial. European journal of endocrinology. 2020;182:195-205. https://doi.org/10.1530/eje-19-0587. 585. Shah MD, Witterick IJ, Eski SJ, Pinto R, Freeman JL. Quality of life in patients undergoing thyroid surgery. The Journal of otolaryngology. 2006;35:209-215. https://doi.org/10.2310/7070.2006.0011. 586. Dogan S, Sahbaz NA, Aksakal N, Tutal F, Torun BC, Yildirim NK, et al. Quality of life after thyroid surgery. Journal of endocrinological investigation. 2017;40:1085-1090. https://doi.org/10.1007/s40618-017-0635-9. 587. Nickel B, Tan T, Cvejic E, Baade P, McLeod DSA, Pandeya N, et al. Health-Related Quality of Life After Diagnosis and Treatment of Differentiated Thyroid Cancer and Association With Type of Surgical Treatment. JAMA otolaryngology - head & neck surgery. 2019;145:231-238. https://doi.org/10.1001/jamaoto.2018.3870. 588. Sorensen JR, Watt T, Cramon P, Dossing H, Hegedus L, Bonnema SJ, et al. Quality of life after thyroidectomy in patients with nontoxic nodular goiter: A prospective cohort study. Head & neck. 2017;39:2232-2240. https://doi. org/10.1002/hed.24886. 589. Buttner M, Locati LD, Pinto M, Araujo C, Tomaszewska IM, Kiyota N, et al. Quality of Life in Patients With Hypoparathyroidism After Treatment for Thyroid Cancer. The Journal of clinical endocrinology and metabolism. 2020;105:e4652–e4660. https://doi.org/10.1210/clinem/dgaa597. 590. Kurumety SK, Helenowski IB, Goswami S, Peipert BJ, Yount SE, Sturgeon C. Post-thyroidectomy neck appearance and impact on quality of life in thyroid cancer survivors. Surgery. 2019;165:1217-1221. https://doi.org/10.1016/j. surg.2019.03.006. 591. Kletzien H, Macdonald CL, Orne J, Francis DO, Leverson G, Wendt E, et al. Comparison Between Patient-Perceived Voice Changes and Quantitative Voice Measures in the First Postoperative Year After Thyroidectomy: A Secondary Analysis of a Randomized Clinical Trial. JAMA otolaryngology - head & neck surgery. 2018;144:995-1003. https://doi. org/10.1001/jamaoto.2018.0309. 592. Goswami S, Peipert BJ, Mongelli MN, Kurumety SK, Helenowski IB, Yount SE, et al. Clinical factors associated with worse quality-of-life scores in United States thyroid cancer survivors. Surgery. 2019;166:69-74. https://doi. org/10.1016/j.surg.2019.01.034. 593. Jeon MJ, Lee YM, Sung TY, Han M, Shin YW, Kim WG, et al. Quality of Life in Patients with Papillary Thyroid Microcarcinoma Managed by Active Surveillance or Lobectomy: A Cross-Sectional Study. Thyroid. 2019;29:956-962. https://doi.org/10.1089/thy.2018.0711. 594. Wong CW, Schumm MA, Zhu CY, Tseng CH, Arasu A, Han J, et al. Quality of Life Following Molecular Marker Testing for Indeterminate Thyroid Nodules. Endocrine practice. 2020;26:960-966. https://doi.org/10.4158/EP-2020-0101. 595. Ware JE, Jr. SF-36 health survey update. Spine. 2000;25:3130-3139. https://doi.org/10.1097/00007632-200012150-00008. 596. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. Journal of health economics. 2002;21:271-292. https://doi.org/10.1016/s0167-6296(01)00130-8. 597. Watt T, Bjorner JB, Groenvold M, Rasmussen AK, Bonnema SJ, Hegedus L, et al. Establishing construct validity for the thyroid-specific patient reported outcome measure (ThyPRO): an initial examination. Quality of life research. 2009;18:483-496. https://doi.org/10.1007/s11136-009-9460-8. 598. Watt T, Bjorner JB, Groenvold M, Cramon P, Winther KH, Hegedus L, et al. Development of a Short Version of the Thyroid-Related Patient-Reported Outcome ThyPRO. Thyroid. 2015;25:1069-1079. https://doi.org/10.1089/ thy.2015.0209. 599. Nordqvist SF, Boesen VB, Rasmussen AK, Feldt-Rasmussen U, Hegedus L, Bonnema SJ, et al. Determining minimal important change for the thyroid-related quality of life questionnaire ThyPRO. Endocr Connect. 2021;10:316-324. https://doi.org/10.1530/EC-21-0026. 600. Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR, Clinical Significance Consensus Meeting G. Methods to explain the clinical significance of health status measures. Mayo Clin Proc. 2002;77:371-383. https://doi. org/10.4065/77.4.371. 601. Ahn J, Jeon MJ, Song E, Kim TY, Kim WB, Shong YK, et al. Quality of Life in Patients with Papillary Thyroid Microcarcinoma According to Treatment: Total Thyroidectomy with or without Radioactive Iodine Ablation. Endocrinology and metabolism. 2020;35:115-121. https://doi.org/10.3803/EnM.2020.35.1.115. 602. Dingle IF, Mishoe AE, Nguyen SA, Overton LJ, Gillespie MB. Salivary morbidity and quality of life following radioactive iodine for well-differentiated thyroid cancer. Otolaryngology - head and neck surgery. 2013;148:746-752. https://doi. org/10.1177/0194599813479777. 603. McClure NS, Sayah FA, Xie F, Luo N, Johnson JA. Instrument-Defined Estimates of the Minimally Important Difference for EQ-5D-5L Index Scores. Value in health. 2017;20:644-650. https://doi.org/10.1016/j.jval.2016.11.015. 604. Henry EB, Barry LE, Hobbins AP, McClure NS, O’Neill C. Estimation of an Instrument-Defined Minimally Important Difference in EQ-5D-5L Index Scores Based on Scoring Algorithms Derived Using the EQ-VT Version 2 Valuation Protocols. Value in health. 2020;23:936-944. https://doi.org/10.1016/j.jval.2020.03.003.
RkJQdWJsaXNoZXIy MTk4NDMw